U. Hoppe

805 total citations
18 papers, 533 citations indexed

About

U. Hoppe is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, U. Hoppe has authored 18 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in U. Hoppe's work include Sexual Differentiation and Disorders (5 papers), Inflammatory mediators and NSAID effects (3 papers) and Asthma and respiratory diseases (3 papers). U. Hoppe is often cited by papers focused on Sexual Differentiation and Disorders (5 papers), Inflammatory mediators and NSAID effects (3 papers) and Asthma and respiratory diseases (3 papers). U. Hoppe collaborates with scholars based in Germany, Netherlands and India. U. Hoppe's co-authors include B. M. Peskar, Bernhard A. Peskar, K. Lange, Olaf Hiort, Paul‐Martin Holterhus, Ralf Werner, Christine Marschke, W. Kozuschek, K Morgenroth and Susanne Thiele and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, FEBS Letters and British Journal of Pharmacology.

In The Last Decade

U. Hoppe

18 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
U. Hoppe Germany	11	188	163	151	97	93	18	533
Nicolas Lembert Germany	15	244 1.3×	254 1.6×	66 0.4×	96 1.0×	89 1.0×	24	620
Joanna Kania Poland	14	200 1.1×	192 1.2×	127 0.8×	44 0.5×	21 0.2×	27	507
Nathan B. Pliam United States	9	238 1.3×	144 0.9×	82 0.5×	42 0.4×	115 1.2×	11	558
Tetsuya Suwa Japan	15	186 1.0×	158 1.0×	41 0.3×	95 1.0×	287 3.1×	55	662
B Panczenko United States	6	110 0.6×	52 0.3×	307 2.0×	85 0.9×	71 0.8×	11	547
Arata Kimura Japan	9	99 0.5×	131 0.8×	171 1.1×	76 0.8×	34 0.4×	12	401
C Pacot France	9	707 3.8×	312 1.9×	68 0.5×	67 0.7×	133 1.4×	14	968
Gracjana Krzysiek-Mączka Poland	15	155 0.8×	179 1.1×	44 0.3×	47 0.5×	27 0.3×	29	512
Gyesik Min United States	16	408 2.2×	96 0.6×	24 0.2×	160 1.6×	91 1.0×	28	947
Timothy J. Williams United States	7	139 0.7×	61 0.4×	181 1.2×	34 0.4×	14 0.2×	9	512

Countries citing papers authored by U. Hoppe

Since Specialization

Citations

This map shows the geographic impact of U. Hoppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Hoppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Hoppe more than expected).

Fields of papers citing papers by U. Hoppe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Hoppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Hoppe. The network helps show where U. Hoppe may publish in the future.

Co-authorship network of co-authors of U. Hoppe

This figure shows the co-authorship network connecting the top 25 collaborators of U. Hoppe. A scholar is included among the top collaborators of U. Hoppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Hoppe. U. Hoppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Tzogani, Kyriaki, et al.. (2013). The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use. Journal of Dermatological Treatment. 25(5). 371–374. 9 indexed citations

Kasperkiewicz, Michael, U. Hoppe, Detlef Zillikens, & Enno Schmidt. (2009). Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Clinical and Experimental Dermatology. 35(6). 614–617. 17 indexed citations

Thiele, Susanne, Ralf Werner, Wiebke Ahrens, et al.. (2007). A Disruptive Mutation in Exon 3 of the GNAS Gene with Albright Hereditary Osteodystrophy, Normocalcemic Pseudohypoparathyroidism, and Selective Long Transcript Variant Gsα-L Deficiency. The Journal of Clinical Endocrinology & Metabolism. 92(5). 1764–1768. 16 indexed citations

Hoppe, U., Lutz Wünsch, Paul‐Martin Holterhus, et al.. (2007). Altered Transcription Profiles of Key-Enzymes of Androgen Biosynthesis in Genital Skin Fibroblasts from Patients with 46,XY Disorders of Sex Development (DSD). Sexual Development. 1(4). 230–237. 4 indexed citations

Hoppe, U., Paul‐Martin Holterhus, Lutz Wünsch, et al.. (2006). Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor. Journal of Molecular Medicine. 84(8). 651–659. 21 indexed citations

Holterhus, Paul‐Martin, Ralf Werner, U. Hoppe, et al.. (2005). Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations. Journal of Molecular Medicine. 83(12). 1005–1013. 26 indexed citations

Thiele, Susanne, U. Hoppe, Paul‐Martin Holterhus, & Olaf Hiort. (2005). Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males. European Journal of Endocrinology. 152(6). 875–880. 24 indexed citations

Hiort, Olaf, Paul‐Martin Holterhus, Ralf Werner, et al.. (2005). Homozygous Disruption of P450 Side-Chain Cleavage (CYP11A1) Is Associated with Prematurity, Complete 46,XY Sex Reversal, and Severe Adrenal Failure. The Journal of Clinical Endocrinology & Metabolism. 90(1). 538–541. 75 indexed citations

Hoppe, U., et al.. (1991). A monoclonal antibody against the sulfidopeptide leukotrienes LTC4, LTD4 and LTE4. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1081(3). 274–278. 16 indexed citations

10.

Peskar, B. M., U. Hoppe, K. Lange, & Bernhard A. Peskar. (1988). Effects of non‐steroidal anti‐inflammatory drugs on rat gastric mucosal leukotriene C₄ and prostanoid release: relation to ethanol‐induced injury. British Journal of Pharmacology. 93(4). 937–943. 35 indexed citations

11.

Hoppe, U., et al.. (1987). Polyneuropathy in Waldenström s macroglobulinaemia. Passive transfer from man to mouse. Acta Neurologica Scandinavica. 75(2). 112–116. 3 indexed citations

12.

Hoppe, U., et al.. (1987). Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.. PubMed. 17A. 339–43. 14 indexed citations

13.

Hoppe, U., et al.. (1987). Release of eicosanoids from human synovial tissue and the effect of anti-inflammatory drugs.. PubMed. 242. 277–82. 2 indexed citations

14.

Kozuschek, W., et al.. (1986). [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].. PubMed. 98(4). 98–104. 7 indexed citations

15.

Hoppe, U., et al.. (1986). Radioimmunoassay for leukotriene E₄. FEBS Letters. 208(1). 26–30. 7 indexed citations

16.

Hoppe, U., et al.. (1986). Leuktriene synthesis by human gastrointestinal tissues. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 878(2). 184–193. 67 indexed citations

17.

Peskar, B. M., K. Lange, U. Hoppe, & Bernhard A. Peskar. (1986). Ethanol stimulates formation of leukotriene C4 in rat gastric mucosa. Prostaglandins. 31(2). 283–293. 188 indexed citations

18.

Lange, K., et al.. (1986). Release and effects of sulfidopeptide-leukotrienes in heart and vascular tissues.. PubMed. 16. 261–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact